Literature DB >> 191528

Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.

C Lopez, R J O'Reilly.   

Abstract

Studies in immunosuppressed and immunodeficient patients indicate that the cell-mediated immune response appears to be responsible for controlling reactivated herpesvirus infections. In this study, the various parameters of a herpesvirus (types 1 and 2) antigen specific lymphocyte proliferation assay were optimized and used to evaluate individuals with clinical, recurrent HSV-1 and HSV-2 infections. Normal individuals with neutralizing antibody to HSV-1 or HSV-2 responded to virus antigen in culture as well as individuals with recurrent disease. Normal individuals without neutralizing antibody responded with a significantly lower response. Specificity of the lymphocyte proliferation assay was observed most strikingly in normal individuals with a rare HSV-1 infection during the vesicular eruption. Specificity was also observed by determining the ratio of the response to HSV-1 as compared to the response to HSV-2. Evaluated in this manner, individuals with recurrent HSV-1 infections had significantly higher ratios than individuals with HSV-2 infections and vice versa. Data from individuals with recurrent disease was compared to that of normal individuals to determine whether the former demonstrated a specific alteration in this response. Individuals with recurrent disease were found to have higher neutralizing antibody titers than normals. The neutralizing antibody titers in normal individuals correlated well with the lymphocyte proliferation assay results, whereas a similar evaluation in individuals with recurrent disease gave a negative correlation. The ratio of HSV-1 response/HSV-2 response also demonstrated a suppressed response in recurrent infections to the homologous virus during active disease, which disappeared when the individual was convalescent. These studies indicate that individuals with recurrent HSV infections have virus antigen specific alterations of their cell-mediated immune response, which can be associated with their disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191528

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].

Authors:  S W Wassilew; I Koch
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

3.  Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.

Authors:  J J Ratner; B A Sanford; K O Smith
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

4.  Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy.

Authors:  R W Price; J Schmitz
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

5.  Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.

Authors:  L Rasmussen; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice.

Authors:  C Lopez; G Dudas
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals.

Authors:  K A Clouse; P W Adams; C G Orosz
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

8.  Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.

Authors:  H Moser; F Behrens; R Ziegelmaier; J Hilfenhaus; R Mauler
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

9.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

10.  Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.

Authors:  H J Zweerink; L Corey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.